Pacific Biosciences of California, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 37.2M | 44.6M | 38.4M | 39.8M | 37.2M | 39.2M | 40.0M | 36.0M |
| Cost of Goods Sold | 24.3M | 27.9M | 23.4M | 25.1M | 38.5M | 29.2M | 30.0M | 30.1M |
| Gross Profit | 12.8M | 16.7M | 15.1M | 14.7M | -1.4M | 10.1M | 10.0M | 5.9M |
| R&D Expenses | 19.6M | 22.9M | 22.8M | 22.5M | 29.1M | 27.5M | 25.5M | 38.5M |
| Operating Expenses | 50.8M | 57.9M | 53.9M | 59.5M | 427.6M | 163.1M | 74.1M | 181.8M |
| Operating Income | -37.9M | -41.2M | -38.8M | -44.9M | -428.9M | -153.0M | -64.1M | -175.8M |
| Other Income / Gains | 29.8M | 1.0M | 1.2M | 3.0M | 2.6M | 155.7M | 3.4M | 2.5M |
| Net Income | -8.3M | -40.4M | -38.0M | -41.9M | -426.1M | 2.4M | -60.7M | -173.3M |
| EPS (Diluted) | -0.03 | -0.13 | -0.13 | -0.14 | -1.44 | 0.008 | -0.22 | -0.64 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.345 | 0.375 | 0.392 | 0.369 | -0.037 | 0.256 | 0.25 | 0.165 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 31.2M | 34.1M | 31.1M | 36.2M | 40.2M | 41.1M | 43.7M | 35.7M |
| Other Expenses | 0 | 1.0M | 0 | 833K | 358.3M | 94.5M | 4.8M | 107.6M |
| Cost And Expenses | 75.1M | 85.8M | 77.3M | 84.6M | 466.1M | 192.3M | 104.0M | 211.9M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | -1.7M | 1.7M | 1.7M | 1.7M | 1.7M | 2.8M | 3.5M | 3.5M |
| Depreciation And Amortization | 4.1M | 4.6M | 4.4M | 4.6M | 372.8M | 10.9M | 16.1M | 14.3M |
| Ebitda | -5.8M | -33.8M | -31.5M | -35.6M | -51.9M | 16.4M | -41.1M | -155.5M |
| Ebitdaratio | -0.155 | -0.757 | -0.819 | -0.895 | -1.396 | 0.418 | -1.028 | -4.318 |
| Operating Income Ratio | -1.02 | -0.923 | -1.01 | -1.128 | -11.545 | -3.901 | -1.603 | -4.883 |
| Income Before Tax | -8.1M | -40.2M | -37.6M | -41.9M | -426.4M | 2.7M | -60.7M | -173.3M |
| Income Before Tax Ratio | -0.218 | -0.90 | -0.979 | -1.054 | -11.476 | 0.069 | -1.519 | -4.813 |
| Income Tax Expense | 184K | 202K | 383K | 35K | -302K | 316K | 0 | 0 |
| Net Income Ratio | -0.223 | -0.904 | -0.989 | -1.054 | -11.468 | 0.06 | -1.519 | -4.813 |
| Epsdiluted | -0.03 | -0.13 | -0.13 | -0.14 | -1.44 | 0.008 | -0.22 | -0.64 |
| Weighted Average Shs Out | 305.8M | 301.9M | 300.8M | 300.2M | 296.9M | 283.0M | 272.9M | 272.4M |
| Weighted Average Shs Out Dil | 305.8M | 301.9M | 300.8M | 300.2M | 296.9M | 306.9M | 272.9M | 272.4M |